ImpriMed, Inc.
Created in 2017
Social networks
3,845Activities
Technologies
Entity types
Location
1130 Independence Ave, Mountain View, CA 94043, USA
Mountain View
United States of America
Employees
Scale: 11-50
Estimated: 38
Engaged corporates
0
0 0Added in Motherbase
1 month ago
pettech Value proposition
AI-driven Personalized Medicine for Cancer Care
ImpriMed, founded in 2017 in Silicon Valley, is a leading precision medicine startup revolutionizing cancer treatment with artificial intelligence. The company’s pioneering drug response prediction technology helps reduce costs, accelerate treatment, enhance efficacy, and improve the quality of life for patients. To date, the company’s technology has been deployed across more than 40 U.S. states, and 17,000+ canine and feline blood cancer tests have been performed as of 2024. ImpriMed is now poised to extend its groundbreaking AI-driven approach to human healthcare, redefining the future of oncology treatment with personalized, effective solutions. For additional information, visit www.imprimedicine.com.
Precision Medicine, Veterinary Medicine, Artificial Intelligence, Biotechnology, Animal Health, Machine Learning, and Canine Lymphoma
ImpriMed | Find the best chemo drugs for treating your dog's lymphoma
At ImpriMed, we understand how overwhelming it can be when your furry friend is diagnosed with lymphoma. That's why we offer advanced testing to help identify the most effective chemotherapy drugs for your dog BEFORE treatment even begins. Make informed decisions about your dog's cancer treatment.
https://www.imprimedicine.com/
